Susanne Kimeswenger

11PUBLICATIONS
55CO-AUTHORS
Molecular targetsMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 05, 2025
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19.

Soyoung Lee, Yong Yu, Jakob Trimpert

|Nov 28, 2024
Darier disease: Current insights and challenges in pathogenesis and management.

Monika Ettinger, Susanne Kimeswenger, Isabella Deli

|Jul 26, 2024
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment.

Matthew Hunt, Nuoqi Wang, Naricha Pupinyo

|Jan 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.

Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger

|Jan 10, 2024
A case of papular acantholytic dyskeratosis with IL-23/TNF-α dominant immune profile.

Monika Ettinger, Teresa Burner, Angelika Lackner

|Nov 18, 2023
Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets.

Monika Ettinger, Teresa Burner, Anshu Sharma

Pageof 2

Frequent Collaborators

3 joint publications

Wolfram Hoetzenecker

3 joint publications

Emmanuella Guenova

2 joint publications

Gagandeep Singh

2 joint publications

Christian Jantschitsch